YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Bifidobacterium infantis OFR-525 Strain Resistant to Rifampicin and Fluoroquinolones

리팜피신과 플로로퀴놀론계 항균제에 내성인 Bifidobacterium infantis OFR-525 균주

  • Published : 1999.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Bifidobacterium infantis K-525 isolated from healthy Korean was susceptible to rifampicin and fluoroquinolones and resistant to other antituberculosis agents. When the preparation of this strain is taken as a therapeutics for human intestinal disorders with rifampicin or fluoroquinolones, its therapeutic effect can not be expected. So, B, infantis RFR-525 resistant to rifampicin was obtained by treating the parent B. infantis 525 with N-methyl-N'-nitro-N-nitrosoguanidine. B. infantis OFR-525 was produced by serial passage of B. infantis RFR-525 on agar with 2-fold minimal inhibitory concentration of ofloxacin. B. infantis OFR-525 was resistant to antituberculosis agents and fluoroquinolones up to 4∼128 fold higher than that for the original strain. The resistance of B. infantis OFR-525 against rifampicin and ofloxacin was maintained in vivo and in vitro. Conclusively, B. infantis OFR-525 can be regarded as a promising strain which can be developed as the preparation for the treatment of the intestinal disorders of the tuberculosis patients under rifampicin and ofloxacin therapy.

Keywords

References

  1. M. Sc. Thesis, Development of Clostridium butyricum resistant to rifampicin Choi. S. S.
  2. Kor. J. Microbiol v.27 Development of Latobacillus sporogenes resistanct to rifampicin, an antituberculosis agent Kim, H. S.;Choi, S. S.;Choi, E. C.(et al.)
  3. Lancet v.1 Lactobacillus preparation fur use with antibiotics I-II-III Cordon, D.;Marcrae, J.;Wheater, D. M.
  4. Zblt. Back.I. Orig. v.195 Eine Vergesserte Methodik der qualitartiven und quantitativen Analyse der Darmflora or Menschen und Tieren Mitsuoka, T;Sega, T.;Yamamoto, S.
  5. J. Natl Cencer Inst. v.54 Large bowl cancer : an epidemiologic jigsaw puzzle Burkitt., D. P.
  6. Cancer Res. v.35 Fecal bateriology of colonic polyp patients and control patients Finegold. S. M.;Flora, D. J. A.
  7. Latic acid bacteria Lactic acid bacteria in health and desease Salminen, S.;Deighton, M.;Grobach, S.;Salminen, S.(ed.);Wright, A. (ed.)
  8. Arch. Pharm. Res. v.21 Inhibitory effects of Bifidobacterium spp. isolated from a healthy Korean on harmful enzymes of human intestinal microflora Park, H. Y.;Choi, S. C.;Kim, D. H.(et al.)
  9. Yakhak Hoeji v.42 Antibiotic susceptibility of Bifidobacterium spp. strains isolated from healthy Korean Chang, H. A.;Choi, K. H.; Oh, T. G.;Kwon, A. R.;Kim, D. H.;Choi, E. C.
  10. Methods for Dilution Antimicrobial Susceptibility Tests for Bateria that Grow Aerobically-third edition : approved standard M7-A3 National Committee for Clinical Laboratory Standards